Xeltis
Series D+Xeltis raised €15M in a Series D+ round in Aug 2022. The company is based in Zurich, Switzerland. Investors in the round: Grand Pharmaceutical Group. Data as of Nov 2026.
Amount raised
€15M
€15,000,000
Native amount
15,000,000 EUR
Stage
Series D+
series d
Investors
1
Provenance & confidence
High confidenceAmount
Reported in EUR — no conversion. €15M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
1 namedDate
Aug 2022
Round type
series d
Amount (EUR)
€15M
Related news
- Dutch-Swiss medtech firm Xeltis lands €15M from EIB for its restorative approach in cardiovascular therapysiliconcanals.com · 2021-11
- Chinese pharma giant backs Dutch medtech Xeltis with €15 milliontech.eu · 2022-08